No es consejo médico. DrPep no vende péptidos. Solo contenido educativo — muchos compuestos son en investigación o no están aprobados por la FDA. Verifica en fuentes primarias y consulta a un clínico autorizado.

← Library

FDA approved

Daptomycin

IV (into a vein) cyclic lipopeptide for complicated skin infections and bacteremia/endocarditis (labeled uses).

Ref $ —reference only

DaptomycinFDA-approved
Skin researchFDA-approved medicine
What it's for

IV (into a vein) cyclic lipopeptide for complicated skin infections and bacteremia/endocarditis (labeled uses).

Guide →

What it's for

Daptomycin is a cyclic lipopeptide antibiotic with activity against many gram-positive pathogens, including some resistant strains. It is used for complicated skin and skin-structure infections and for Staphylococcus aureus bloodstream infections including right-sided endocarditis, per labeling.

What it does for the body

It is used for complicated skin and skin-structure infections and for Staphylococcus aureus bloodstream infections including right-sided endocarditis, per labeling. It is not for pneumonia (inactivated by lung surfactant).

What it targets

Calcium-dependent insertion into the bacterial membrane causes rapid depolarization and potassium efflux, killing the organism without classic cell-wall lysis alone. Researchers map these ideas in cells and animals first; human proof has to clear a higher bar.

Research context

Bottom line for readers: Daptomycin has a defined FDA-approved story. Use the citations tab to open labels and trial registries, and treat anything beyond the label as unverified.

Studied for (literature interest)

  • Skin research interest (educational tag)

Cautions (educational)

  • Educational only — not medical advice.
  • DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.

Citations / starters

Reference

No ref on file.

Send me a message

Or email directly:info@drpep.ai